BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 33848118)

  • 1. Intracellular Synthesis of Hybrid Gallium-68 Nanoparticle Enhances MicroPET Tumor Imaging.
    Chen P; Wang H; Wu H; Zou P; Wang C; Liu X; Pan Y; Liu Y; Liang G
    Anal Chem; 2021 Apr; 93(16):6329-6334. PubMed ID: 33848118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Furin-Guided Intracellular
    Wang H; Chen P; Wu H; Zou P; Wu J; Liu Y; Liang G
    Anal Chem; 2019 Dec; 91(23):14842-14845. PubMed ID: 31718142
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of Cu-64 and Ga-68 Radiolabeled Glucagon-Like Peptide-1 Receptor Agonists as PET Tracers for Pancreatic β cell Imaging.
    Bandara N; Zheleznyak A; Cherukuri K; Griffith DA; Limberakis C; Tess DA; Jianqing C; Waterhouse R; Lapi SE
    Mol Imaging Biol; 2016 Feb; 18(1):90-8. PubMed ID: 25987465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preclinical comparison of Al18F- and 68Ga-labeled gastrin-releasing peptide receptor antagonists for PET imaging of prostate cancer.
    Chatalic KL; Franssen GM; van Weerden WM; McBride WJ; Laverman P; de Blois E; Hajjaj B; Brunel L; Goldenberg DM; Fehrentz JA; Martinez J; Boerman OC; de Jong M
    J Nucl Med; 2014 Dec; 55(12):2050-6. PubMed ID: 25413139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiolabeled B9958 Derivatives for Imaging Bradykinin B1 Receptor Expression with Positron Emission Tomography: Effect of the Radiolabel-Chelator Complex on Biodistribution and Tumor Uptake.
    Zhang Z; Amouroux G; Pan J; Jenni S; Zeisler J; Zhang C; Liu Z; Perrin DM; Bénard F; Lin KS
    Mol Pharm; 2016 Aug; 13(8):2823-32. PubMed ID: 27348517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biodistribution of
    Tishchenko VK; Petriev VM; Mikhailovskaya AA; Shegai PV; Ivanov SA; Kaprin AD
    Bull Exp Biol Med; 2021 Jan; 170(3):345-349. PubMed ID: 33452982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
    Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
    Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
    Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
    Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enzyme-Controlled Intracellular Self-Assembly of (18)F Nanoparticles for Enhanced MicroPET Imaging of Tumor.
    Liu Y; Miao Q; Zou P; Liu L; Wang X; An L; Zhang X; Qian X; Luo S; Liang G
    Theranostics; 2015; 5(10):1058-67. PubMed ID: 26199645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of
    Zhao M; Yang W; Zhang M; Li G; Wang S; Wang Z; Ma X; Kang F; Wang J
    Tumour Biol; 2016 Sep; 37(9):12123-12131. PubMed ID: 27220318
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Wei X; Liu Z; Zhao Z
    Hell J Nucl Med; 2019; 22(1):78-79. PubMed ID: 30968863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, Synthesis, and Biological Evaluation of
    Liu F; Liu T; Xu X; Guo X; Li N; Xiong C; Li C; Zhu H; Yang Z
    Mol Pharm; 2018 Feb; 15(2):619-628. PubMed ID: 29278911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 68Ga-DOTA-NGR as a novel molecular probe for APN-positive tumor imaging using MicroPET.
    Zhang J; Lu X; Wan N; Hua Z; Wang Z; Huang H; Yang M; Wang F
    Nucl Med Biol; 2014 Mar; 41(3):268-75. PubMed ID: 24438818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor Targeting via Sialic Acid: [
    Tsoukalas C; Geninatti-Crich S; Gaitanis A; Tsotakos T; Paravatou-Petsotas M; Aime S; Jiménez-Juárez R; Anagnostopoulos CD; Djanashvili K; Bouziotis P
    Mol Imaging Biol; 2018 Oct; 20(5):798-807. PubMed ID: 29464496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a 67Ga/68Ga radiopharmaceutical for SPECT and PET of MDR1 P-glycoprotein transport activity in vivo: validation in multidrug-resistant tumors and at the blood-brain barrier.
    Sharma V; Prior JL; Belinsky MG; Kruh GD; Piwnica-Worms D
    J Nucl Med; 2005 Feb; 46(2):354-64. PubMed ID: 15695797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical evaluation of melanocortin-1 receptor (MC1-R) specific
    Nagy G; Dénes N; Kis A; Szabó JP; Berényi E; Garai I; Bai P; Hajdu I; Szikra D; Trencsényi G
    Eur J Pharm Sci; 2017 Aug; 106():336-344. PubMed ID: 28625749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and evaluation of a novel urea-based
    Zha Z; Ploessl K; Choi SR; Wu Z; Zhu L; Kung HF
    Nucl Med Biol; 2018 Apr; 59():36-47. PubMed ID: 29459281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin B-Activated PET Tracer for
    Li H; Liang B; Gao X; Peng Y; Liu Q; Qiu L; Lin J
    Mol Pharm; 2024 Mar; 21(3):1382-1389. PubMed ID: 38372213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The practicality of nanoceria-PAN-based (68)Ge/(68)Ga generator toward preparation of (68)Ga-labeled cyclic RGD dimer as a potential PET radiotracer for tumor imaging.
    Chakraborty S; Chakravarty R; Sarma HD; Dash A; Pillai MR
    Cancer Biother Radiopharm; 2013 Feb; 28(1):77-83. PubMed ID: 22967229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.